DE2967701D1 - A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus. - Google Patents

A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus.

Info

Publication number
DE2967701D1
DE2967701D1 DE7979302216T DE2967701T DE2967701D1 DE 2967701 D1 DE2967701 D1 DE 2967701D1 DE 7979302216 T DE7979302216 T DE 7979302216T DE 2967701 T DE2967701 T DE 2967701T DE 2967701 D1 DE2967701 D1 DE 2967701D1
Authority
DE
Germany
Prior art keywords
production
pharmaceutical compositions
producing microorganism
antibiotic mixture
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE7979302216T
Other languages
German (de)
English (en)
Inventor
Robert L Hamill
Marvin Martin Hoehn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE2967701D1 publication Critical patent/DE2967701D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
DE7979302216T 1978-10-16 1979-10-15 A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus. Expired - Lifetime DE2967701D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/951,695 US4208403A (en) 1978-10-16 1978-10-16 A-21978 Antibiotics and process for their production

Publications (1)

Publication Number Publication Date
DE2967701D1 true DE2967701D1 (de) 1990-11-15

Family

ID=25492027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE7979302216T Expired - Lifetime DE2967701D1 (de) 1978-10-16 1979-10-15 A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus.

Country Status (36)

Country Link
US (1) US4208403A (OSRAM)
EP (1) EP0010421B1 (OSRAM)
JP (2) JPS5592353A (OSRAM)
AR (1) AR221738A1 (OSRAM)
AT (1) AT365235B (OSRAM)
AU (1) AU531616B2 (OSRAM)
BE (1) BE879401A (OSRAM)
BG (1) BG41138A3 (OSRAM)
CA (1) CA1137900A (OSRAM)
CH (1) CH655127A5 (OSRAM)
CS (1) CS219259B2 (OSRAM)
DD (1) DD146618A5 (OSRAM)
DE (1) DE2967701D1 (OSRAM)
DK (1) DK148918C (OSRAM)
DO (1) DOP1979002809A (OSRAM)
EG (1) EG14631A (OSRAM)
ES (1) ES485074A1 (OSRAM)
FI (1) FI65631C (OSRAM)
FR (1) FR2444079A1 (OSRAM)
GB (1) GB2031437B (OSRAM)
GR (1) GR73146B (OSRAM)
GT (1) GT196000041A (OSRAM)
HK (1) HK42987A (OSRAM)
HU (1) HU180746B (OSRAM)
IE (1) IE48564B1 (OSRAM)
IL (1) IL58448A (OSRAM)
LU (1) LU81794A1 (OSRAM)
MY (1) MY8500568A (OSRAM)
NZ (1) NZ191822A (OSRAM)
PH (1) PH16248A (OSRAM)
PL (1) PL122756B1 (OSRAM)
PT (1) PT70298A (OSRAM)
RO (1) RO77097A (OSRAM)
SU (1) SU1071226A3 (OSRAM)
YU (1) YU247079A (OSRAM)
ZA (1) ZA795435B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32311E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32310E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
DD238068A5 (de) * 1984-10-09 1986-08-06 ���@�����@�K@�������k�� Verfahren zur herstellung von derivaten der cyclopeptidantibiotika a-21978 c
US4800157A (en) * 1985-09-09 1989-01-24 Eli Lilly And Company Process for producing the A-21978C antibiotics
US4874843A (en) * 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
JP2863934B2 (ja) * 1989-07-24 1999-03-03 塩野義製薬株式会社 抗生物質プラスバシン
US7235651B2 (en) * 2001-12-26 2007-06-26 Cubist Pharmaceuticals, Inc. Genes and proteins involved in the biosynthesis of lipopeptides
CN101165168B (zh) * 2006-10-20 2010-05-12 上海爱普香料有限公司 一株链霉菌及利用其生物转化阿魏酸生产香兰素的方法
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici

Also Published As

Publication number Publication date
RO77097A (ro) 1981-06-22
IL58448A0 (en) 1980-01-31
FI793190A7 (fi) 1980-04-17
CS219259B2 (en) 1983-03-25
ZA795435B (en) 1981-05-27
SU1071226A3 (ru) 1984-01-30
DK148918B (da) 1985-11-18
PT70298A (en) 1979-11-01
HU180746B (en) 1983-04-29
JPS5592353A (en) 1980-07-12
ATA669979A (de) 1981-05-15
NZ191822A (en) 1982-09-14
FI65631C (fi) 1984-06-11
AU5175779A (en) 1980-04-24
PL218977A1 (OSRAM) 1980-06-16
PH16248A (en) 1983-08-16
DK434479A (da) 1980-05-14
IE791948L (en) 1980-04-16
MY8500568A (en) 1985-12-31
AU531616B2 (en) 1983-09-01
PL122756B1 (en) 1982-08-31
FI65631B (fi) 1984-02-29
CA1137900A (en) 1982-12-21
EP0010421A1 (en) 1980-04-30
ES485074A1 (es) 1980-06-16
AT365235B (de) 1981-12-28
CH655127A5 (fr) 1986-03-27
IL58448A (en) 1983-03-31
GR73146B (OSRAM) 1984-02-10
GB2031437B (en) 1982-10-27
JPH0123479B2 (OSRAM) 1989-05-02
FR2444079A1 (fr) 1980-07-11
DOP1979002809A (es) 1987-12-03
US4208403A (en) 1980-06-17
GT196000041A (es) 1981-04-04
DD146618A5 (de) 1981-02-18
GB2031437A (en) 1980-04-23
LU81794A1 (fr) 1980-05-07
AR221738A1 (es) 1981-03-13
EP0010421B1 (en) 1990-10-10
BE879401A (fr) 1980-04-15
YU247079A (en) 1982-10-31
HK42987A (en) 1987-06-05
EG14631A (en) 1985-03-31
DK148918C (da) 1986-05-12
IE48564B1 (en) 1985-03-06
JPS6455184A (en) 1989-03-02
FR2444079B1 (OSRAM) 1983-08-05
BG41138A3 (bg) 1987-04-15

Similar Documents

Publication Publication Date Title
DE3381680D1 (de) 1,4-dihydropyridincarbonsaeure-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3763421D1 (de) Polybuten- und polyisobutenamine, verfahren zu deren herstellung und diese enthaltende kraft- und schmierstoffzusammensetzungen.
DE3381772D1 (de) Substituierte azabicyclo-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3575724D1 (de) Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3784401D1 (de) Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
ATE1524T1 (de) Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE32459T1 (de) Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE3673822D1 (de) Benzofuran-2-yl-imidazole mit pharmazeutischer wirkung, ihre salze und relevante verfahren zu ihrer herstellung.
DE3574706D1 (de) Chartreusin-derivate, ihre salze, antitumorale zusammensetzungen und verfahren zu ihrer herstellung.
DE3870065D1 (de) Zusammensetzungen von polyarylalkanoligomeren, verfahren zu deren herstellung.
ATE915T1 (de) N,n-dimethyl-o-pyrazolyl-carbaminsaeureester, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
DE3682370D1 (de) 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE10498T1 (de) Durch purinbasen substituierte alkylamino-desoxy1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
DE3483628D1 (de) 1,n-diaryl-4,5-dihydro-1h-pyrazol-3-amine, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
DE3773240D1 (de) Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
DE3684803D1 (de) Dihydropyridin-alkanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE16007T1 (de) Insektizide, mitizide und nematozide oximphosphatverbindungen und verfahren zu ihrer herstellung.
ATA437279A (de) Phenanthrenderivate, verfahren zu deren herstellung sowie die phenanthren- derivate enthaltenden pharmazeutischen zusammensetzungen
DE3867861D1 (de) Mehlzusammensetzung und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8364 No opposition during term of opposition